BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34598432)

  • 21. COVID-19 versus influenza A/B supeRInfectionS in the IntenSive care unit (CRISIS): Protocol for a Danish nationwide cohort study.
    Mikkelsen VS; Helleberg M; Haase N; Møller MH; Granholm A; Storgaard M; Jonsson AB; Schønning K; Reiter N; Sigurðsson SÞ; Voldstedlund M; Christensen S; Perner A
    Acta Anaesthesiol Scand; 2021 Oct; 65(9):1345-1350. PubMed ID: 34086975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of coexisting pathogens in nasopharyngeal swabs from COVID-19.
    Gao Z; Yu L; Cao L; Yang M; Li Y; Lan Y; Tang R; Huang Y; Luan G; Liu Y; Yu H; Jian L; Zha Y; Fan Z; Bai Y; Luo M; He M; Deng S
    Front Cell Infect Microbiol; 2023; 13():1140548. PubMed ID: 37424777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons.
    Oliva J; Terrier O
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory infections in Coronavirus disease 2019.
    Del Pozo JL
    Rev Esp Quimioter; 2022 Apr; 35 Suppl 1(Suppl 1):64-66. PubMed ID: 35488830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of early- and late-onset bacterial, viral, and fungal respiratory superinfections in invasively ventilated COVID-19 patients.
    Paparoupa M; Aldemyati R; Roggenkamp H; Berinson B; Nörz D; Olearo F; Kluge S; Roedl K; de Heer G; Wichmann D
    J Med Virol; 2022 May; 94(5):1920-1925. PubMed ID: 34951498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers.
    Van Laethem J; Wuyts S; Van Laere S; Koulalis J; Colman M; Moretti M; Seyler L; De Waele E; Pierard D; Lacor P; Allard SD
    Intern Emerg Med; 2022 Jan; 17(1):141-151. PubMed ID: 34185257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?
    Clancy CJ; Nguyen MH
    Clin Infect Dis; 2020 Dec; 71(10):2736-2743. PubMed ID: 32361747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients.
    Parrill A; Tsao T; Dong V; Huy NT
    J Microbiol Immunol Infect; 2021 Feb; 54(1):105-108. PubMed ID: 32943328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: A nationwide survey by the Japanese Respiratory Society.
    Takazono T; Mukae H; Izumikawa K; Kakeya H; Ishida T; Hasegawa N; Yokoyama A
    Respir Investig; 2022 Jan; 60(1):154-157. PubMed ID: 34656520
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Rangel K; Chagas TPG; De-Simone SG
    Pathogens; 2021 Aug; 10(8):. PubMed ID: 34451470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation.
    Mazzariol A; Benini A; Unali I; Nocini R; Smania M; Bertoncelli A; De Sanctis F; Ugel S; Donadello K; Polati E; Gibellini D
    Front Cell Infect Microbiol; 2021; 11():683409. PubMed ID: 34458159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Bacterial and Fungal Superinfection in Critical COVID-19.
    Seitz T; Holbik J; Grieb A; Karolyi M; Hind J; Gibas G; Neuhold S; Zoufaly A; Wenisch C
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coinfections by SARS-CoV-2 and other respiratory viruses and their clinical outcome].
    Fernandes-Matano L; Monroy-Muñoz IE; Uribe-Noguez LA; Hernández-Cueto MLÁ; Sarquiz-Martínez B; Pardavé-Alejandre HD; Coy-Arechavaleta AS; Alvarado-Yaah JE; Rojas-Mendoza T; Santacruz-Tinoco CE; Grajales-Muñiz C; Borja-Aburto VH; Muñoz-Medina JE
    Rev Med Inst Mex Seguro Soc; 2021 Nov; 59(6):482-489. PubMed ID: 34908381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Viral Infection and Bacterial Coinfection and Superinfection in Coronavirus Disease 2019 Patients Presenting to the Emergency Department Using the 29-mRNA Host Response Classifier IMX-BVN-3: A Multicenter Study.
    Bauer W; Gläser S; Thiemig D; Wanner K; Peric A; Behrens S; Bialas J; Behrens A; Galtung N; Liesenfeld O; Sun L; May L; Mace S; Ott S; Vesenbeckh S
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac437. PubMed ID: 36111173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial coinfections and superinfections in critical COVID-19: a Kenyan retrospective cohort analysis.
    Rakiro J; Shah J; Waweru-Siika W; Wanyoike I; Riunga F
    IJID Reg; 2021 Dec; 1():41-46. PubMed ID: 35721772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19: Impact on prescribing and antimicrobial resistance.
    Ruiz-Garbajosa P; Cantón R
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):63-68. PubMed ID: 34598431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to the Letter to the Editor on "Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS-CoV-2 infection than negative patients and are associated to a worse outcome".
    De Francesco MA; Piva S; Pellizzeri S; Signorini L; Fumarola B; Corbellini S; Piccinelli G; Simonetti F; Carta V; Mangeri L; Padovani M; Vecchiati D; Latronico N; Castelli F; Caruso A
    J Med Virol; 2023 Oct; 95(10):e29192. PubMed ID: 37855669
    [No Abstract]   [Full Text] [Related]  

  • 40. Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France.
    Le Hingrat Q; Bouzid D; Choquet C; Laurent O; Lescure FX; Timsit JF; Houhou-Fidouh N; Casalino E; Lucet JC; Descamps D; Visseaux B
    Influenza Other Respir Viruses; 2021 Jul; 15(4):425-428. PubMed ID: 33817971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.